Savill Corrine

CIK 00018375241 companyCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001837524

Recent Transactions

27 trades

Award
Cullinan Therapeutics, Inc.$CGEM
Stock Option (Right to Buy)
2026-02-18+175,000→ 175,000 total
Award
Cullinan Therapeutics, Inc.$CGEM
Stock Option (Right to Buy)
2025-02-19+75,000→ 75,000 total
Award
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2025-02-19+37,500→ 240,990 total
Award
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2024-02-22+37,500→ 203,490 total
Award
Cullinan Therapeutics, Inc.$CGEM
Stock Option (Right to Buy)
2024-02-22+75,000→ 75,000 total
Exercise/Conversion
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2024-02-01$4.30/sh+40,000→ 205,990 total
Exercise/Conversion
Cullinan Therapeutics, Inc.$CGEM
Stock Option (Right to Buy)
2024-02-01−40,000→ 70,331 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2024-02-01$16.18/sh−40,000→ 165,990 total
Exercise/Conversion
Cullinan Therapeutics, Inc.$CGEM
Stock Option (Right to Buy)
2024-01-29−26,003→ 110,331 total
Exercise/Conversion
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2024-01-29$4.30/sh+40,000→ 205,990 total
Exercise/Conversion
Cullinan Therapeutics, Inc.$CGEM
Stock Option (Right to Buy)
2024-01-29−13,997→ 0 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2024-01-29$14.09/sh−40,000→ 165,990 total
Exercise/Conversion
Cullinan Therapeutics, Inc.$CGEM
Stock Option (Right to Buy)
2024-01-23−21,316→ 13,997 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2024-01-23$12.46/sh−21,316→ 165,990 total
Exercise/Conversion
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2024-01-23$4.30/sh+21,316→ 187,306 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2024-01-22$12.18/sh−14,559→ 170,115 total
Exercise/Conversion
Cullinan Therapeutics, Inc.$CGEM
Stock Option (Right to Buy)
2024-01-22−14,559→ 35,313 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2024-01-22$12.02/sh−4,125→ 165,990 total
Exercise/Conversion
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2024-01-22$4.30/sh+14,559→ 184,674 total
Award
Cullinan Therapeutics, Inc.$CGEM
Stock Option (Right to Buy)
2023-02-17+41,000→ 41,000 total
Award
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2023-02-17+20,500→ 170,115 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2022-07-19$15.22/sh−14,958→ 149,615 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2022-07-18$15.06/sh−5,042→ 164,573 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2022-07-11$13.85/sh−200→ 169,615 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2022-07-11$13.33/sh−39,800→ 169,815 total
Award
Cullinan Therapeutics, Inc.$CGEM
Stock Option (Right to Buy)
2022-02-11+33,000→ 33,000 total
Award
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2022-02-11+16,500→ 209,615 total

Companies

Cullinan Therapeutics, Inc.
Chief Business Officer
$CGEM

Recent Filings

Address

C/O CULLINAN THERAPEUTICS, INC. ONE MAIN STREET, SUITE 1350

CAMBRIDGE, MA, 02142

View on SEC.gov